Skip to main content
Clinical Trials/IRCT20211127053190N1
IRCT20211127053190N1
Recruiting
Phase 2

Comparative evaluation of cardiovascular effects of 0.5% Ropivacaine front 2% Lidocaine with 1:80000 epinephrine in implant surgery, A double-blind crossover clinical trial

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Hemodynamic effects.
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
18
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients who need to place 1 implant bilaterally in the posterior areas (premolar or molar) in one jaw
  • Systemically healthy individuals (ASA I)

Exclusion Criteria

  • Patients with a history of allergy to local anesthetic agents, amides and sulfides
  • Patients with acute or chronic infection near the surgical site
  • Alcohol consumption
  • Consumers of antipsychotic drugs, antidepressants and oral contraceptives
  • People who have taken painkillers in the 48 hours before surgery
  • People with a history of chronic facial pain
  • Pregnant and lactating women
  • Patients who need immediate implant placement (class1\)
  • Patients who need open / closed sinus lift surgery at the surgical site
  • Patients who need bone augmentation (GBR) at the surgical site

Outcomes

Primary Outcomes

Not specified

Similar Trials